Frailties and critical issues in neuromuscular diseases highlighted by SARS-CoV-2 pandemic: how many patients are still "invisible"?
Acta Myol
; 41(1): 24-29, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1812153
ABSTRACT
Almost 90% of neuromuscular diseases (NMDs) are classified as rare diseases, defined as conditions affecting less than 5 individuals in 10.000 (0.05%). Their rarity and diversity pose specific challenges for healthcare and research. Epidemiological data on NMDs are often lacking and incomplete. The COVID-19 pandemic has further highlighted the management difficulties of NMDs patients and the necessity to continue the program of implementation of standard of care. This article summarizes the Italian experience during pandemic.
Palabras clave
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Fragilidad
/
COVID-19
/
Enfermedades Neuromusculares
Tipo de estudio:
Estudio observacional
Límite:
Humanos
Idioma:
Inglés
Revista:
Acta Myol
Asunto de la revista:
Cardiología
/
Fisiología
Año:
2022
Tipo del documento:
Artículo
País de afiliación:
2532-1900-065
Similares
MEDLINE
...
LILACS
LIS